Esophagitis, Treatment-Related Toxicity in Non-Small Cell Lung Cancer

被引:40
作者
Bar-Ad, Voichita [1 ]
Ohri, Nitin [1 ]
Werner-Wasik, Maria [1 ]
机构
[1] Thomas Jefferson Univ Hosp, Dept Radiat Oncol, 111 South 11th St, Philadelphia, PA 19107 USA
关键词
Esophagitis; Radiotherapy; Non-Small Cell Lung Cancer;
D O I
10.2174/157488712799363235
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: Radiation esophagitis represents a significant complication experienced by non-small cell cancer (NSCLC) patients receiving thoracic irradiation. The objective of the current review was to assess the clinical and dosimetrical parameters that may predict radiation esophagitis. Methods: Studies were identified by searching PubMed electronic databases. Both prospective and retrospective studies were included. Information regarding clinical and dosimetrical parameters predicting for radiation-induced esophagitis was extracted and analyzed. Results: The esophageal clinical and dosimetric parameters that best predict acute esophagitis remain unclear. In many reports, Vx (the volume of esophagus receiving x Gy) stands out, with values of x ranging from 20-70 Gy. Other studies conclude that the maximal dose received by any point of the esophagus is the best predictor of esophagitis. Another metric implicated with esophageal toxicity in some reports is the proportion of the esophageal circumference or surface area that receives high doses of radiation. Conclusions: Technological advancements in patient immobilization, setup verification, and radiotherapy delivery are increasingly being employed to limit the toxicity of thoracic irradiation. Future efforts are required to determine how these complex techniques should best be implemented to minimize the risks of acute and long-term esophageal injury.
引用
收藏
页码:31 / 35
页数:5
相关论文
共 45 条
[1]   Dosimetric and clinical predictors for radiation-induced esophageal injury [J].
Ahn, SJ ;
Kahn, D ;
Zhou, SM ;
Yu, XL ;
Hollis, D ;
Shafman, TD ;
Marks, LB .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (02) :335-347
[2]   Radiotherapy or chemotherapy followed by radiotherapy with or without amifostine in locally advanced lung cancer [J].
Antonadou, D .
SEMINARS IN RADIATION ONCOLOGY, 2002, 12 (01) :50-58
[3]   A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable nonsmall cell lung cancer: final report of an Australian multi-centre trial [J].
Ball, D ;
Bishop, J ;
Smith, J ;
O'Brien, P ;
Davis, S ;
Ryan, G ;
Olver, I ;
Toner, G ;
Walker, Q ;
Joseph, D .
RADIOTHERAPY AND ONCOLOGY, 1999, 52 (02) :129-136
[4]   Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy [J].
Belderbos, J ;
Heemsbergen, W ;
Hoogeman, M ;
Pengel, K ;
Rossi, M ;
Lebesque, J .
RADIOTHERAPY AND ONCOLOGY, 2005, 75 (02) :157-164
[5]   Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma [J].
Bradley, J ;
Graham, MV ;
Winter, K ;
Purdy, JA ;
Komaki, R ;
Roa, WH ;
Ryu, JK ;
Bosch, W ;
Emami, B .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (02) :318-328
[6]   Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma [J].
Bradley, J ;
Deasy, JO ;
Bentzen, S ;
El Naqa, I .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (04) :1106-1113
[7]   Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer [J].
Bradley, J ;
Thorstad, WL ;
Mutic, S ;
Miller, TR ;
Dehdashti, F ;
Siegel, BA ;
Bosch, W ;
Bertrand, RJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (01) :78-86
[8]   Phase III randomized trial of amifostine as a radioprotector in head and neck cancer [J].
Brizel, DM ;
Wasserman, TH ;
Henke, M ;
Strnad, V ;
Rudat, V ;
Monnier, A ;
Eschwege, F ;
Zhang, J ;
Russell, L ;
Oster, W ;
Sauer, R .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (19) :3339-3345
[9]   Failure Patterns and Toxicity of Concurrent Proton Therapy and Chemotherapy for Stage III Non-small Cell Lung Cancer [J].
Chang, J. Y. ;
Komaki, R. ;
Bucci, M. K. ;
Lu, C. ;
Wen, H. Y. ;
DeGracia, B. ;
Gillin, M. ;
Mohan, R. ;
Cox, J. D. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03) :S446-S447
[10]   STEREOTACTIC BODY RADIATION THERAPY IN CENTRALLY AND SUPERIORLY LOCATED STAGE I OR ISOLATED RECURRENT NON-SMALL-CELL LUNG CANCER [J].
Chang, Joe Y. ;
Balter, Peter A. ;
Dong, Lei ;
Yang, Qiuan ;
Liao, Zhongxing ;
Jeter, Melenda ;
Bucci, M. Kara ;
McAleer, Mary F. ;
Mehran, Reza J. ;
Roth, Jack A. ;
Komaki, Ritsuko .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (04) :967-971